Patient-Focused Drug Development

PharmaVoice

Biopharmaceutical companies and regulators are working to put the patient at the center of drug research and development. Today’s advanced technologies are a key component of their efforts in making clinical trials truly patient-centric.

Hear from ERT’s Jim Munz and Karin Beckstrom and other industry experts on how new technologies are helping biopharmaceutical companies bring more of the patient voice into the clinical development process.

ERT_Patient Focused Drug Development_PharmaVoice_April 2019
Share